TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.
TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.